{Reference Type}: Journal Article
{Title}: The p38/MAPK pathway as a therapeutic target to prevent therapeutic escape of breast cancer stem cells.
{Author}: Yan W;Wang X;Wang W;Guo Q;Huang N;Chen H;Liang XJ;Han Y;Liu D;Zhang J;
{Journal}: Sci China Life Sci
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 26
{Factor}: 10.372
{DOI}: 10.1007/s11427-023-2585-5
{Abstract}: Cancer stem cells (CSCs) play an important role in metastasis development, tumor recurrence, and treatment resistance, and are essential for the eradication of cancer. Currently, therapies fail to eradicate CSCs due to their therapeutic stress-induced cellular escape, which leads to enhanced aggressive behaviors compared with CSCs that have never been treated. However, the underlying mechanisms regulating the therapeutic escape remain unknown. To this end, we established a model to isolate the therapeutic escaped CSCs (TSCSCs) from breast CSCs and performed the transcription profile to reveal the mechanism. Mechanistically, we demonstrated that the behavior of therapeutic escape was regulated through the p38/MAPK signaling pathway, resulting in TSCSCs exhibiting enhanced motility and metastasis. Notably, blocking the p38/MAPK signaling pathway effectively reduced motility and metastasis ability both in vitro and in vivo, which were further supported by downregulated motility-related genes and epithelial-mesenchymal transition (EMT)-related proteins vimentin and N-cadherin. The obtained findings reveal the p38/MAPK pathway as a potential therapeutic target for TSCSCs and would provide profound implications for cancer therapy.